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Control DOB DOB + RAP
MV02 diameter MV02 %~ in MV02 %.1. in({Lm) diameter diameter
Normal 11 ±1 60 ± 5 23 ± 2 24 ± 4 39 ± 7 43 ± 6
OM 21 ± 7 78 ± 6 36 ± 13 17 ± 5 40± 13 14± 3'
OM + SO 16 ± 3 82 ± 9 22 ± 1 20± 3 41 ± 5 37 ± 7
Richard F. Ammar, Jr., David D. Gutterman, Kevin C. Dellsperger. University of Iowa,
Iowa City, IA
Our laboratory has previously demonstrated that nitric oxide (NO) medi-
ates coronary arteriolar dilation to increased myocardial oxygen consump-
tion (MV02). NO mediated dilation has been shown to be attenuated in di-
abetes (OM), and endoperoxide antagonists restore this dilation to normal.
We, therefore, studied the effect of OM on metabolically mediated dilation
of coronary arterioles. We further tested the effect of S029548 (SO; throm-
boxane A2 and prostaglandin H2 receptor antagonist) on coronary arterio-
lar dilatory responses to increased MV02 in OM. We measured changes
in epicardial arteriolar diameters in 5 OM (1 week alloxan, 60 mglkg, iv), 4
OM after administration of SO (2 mglkg. iv), and 6 normal dogs during in-
creased MV02, using dobutamine (DOB; 10{Lglkg/min. iv) with rapid atrial
pacing (RAP; 288 ± 4 bpm). Diameters were measured using intravital mi-
croscopy in anesthetized dogs with stroboscopic epi-illumination coupled to
the cardiac cycle. Mean aortic pressure and blood gases were monitored
and kept constant throughout the protocol. Results:
Background: A polymorphic marker of the ACE gene has been related to
Methods and Results: We therefore studied the effects of intracoronary
acetylcholine (ACh), which stimulates the endothelial release of EDRF, on
blood flow and platelet cGMP content in 14 patients with agiographically
normal coronary arteries undergoing cardiac catheterization. Seven patients
received sodium nitroprusside (SNP) infusions. Blood flow was derived from
Doppler flow velocity, and diameter was measured by quantitative angiog-
raphy. Simultaneous samples were drawn from the great cardiac vein for
measurement of platelet cGMP content by radioimmunoassay. During ACh
infusion (30 {Lg/min} there was a transient increase in both coronary flow
138 ± 25% (mean ± SEM, p < 0.01) and platelet cGMP content (34 ± 13%.
p < 0.01). that returned to baseline (both p < 0.01). Epicardial diameter re-
sponses to ACh were heterogenous: seven patients showed constriction
(-7 ± 2%) and seven showed dilatation (11 ± 2%). Changes in platelet cGM P
content and epicardial diameter paralleled each other: in patients with di-
latation. ACh increased cGMP content significantly (54 ± 22%, P < 0.02),
whereas in those with constriction the change in cGMP was insignificant (14
± 8%, P = NS). During SNP infusion (40 {Lg/min) flow increased by 127 ±
23% and cGMP content by 226 ± 55% (p < 0.02).
Conclusions: 1) luminal release of EDRF in the human coronary circula-
tion causes an increase in platelet cGMP content; 2) this effect is less evi-
dent in patients with impaired endothelial-mediated vasodilation. Failure of
this platelet inhibitory effect in patients with atherosclerosis and endothelial
dysfunction may contribute to their increased susceptibility to thrombotic
vascular events.
mean ± SEM, • P < 0.05 vs. Normal. MV02 is ml/min/100 9
In OM animals, during DOB + RAP. arterial-venous oxygen difference in-
creased as flow decreased. thus keeping MVOz similar. Thus, coronary arteri-
oles in diabetes demonstrate attenuated microvascular dilation to increased
myocardial oxygen consumption. and vasoconstrictor endoperoxides playa
key role in this impaired response.
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1765-61 Thromboxane Mediates Impaired Coronary
Microvascular Responses to Metabolic Stimulation in
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Superoxide anion (°2-), a moiety that rapidly inactivates nitric oxide, is
present in elevated concentrations in the vessel wall following balloon vas-
cular injury. Recent data suggest that 02- is involved in the abnormal
endothelium-dependent vasomotor responses of the regenerated endothe-
lium.
To investigate the hypothesis that polyethyleneglycol superoxide dismu-
tase (PEG-SOD) can effectively scavenge 02- in the vessel wall, ten pigs
were subjected to balloon injury of the left anterior descending or left circum-
flex coronary artery, then maintained on normal lab diets for 28 days. On day
29 five pigs (RX group) began receiving daily intravenous infusions of PEG-
SOD (12,000 Ulkg day 1, then 6,000 Ulkg days 2-5) while five pigs received no
PEG-SOD therapy (NO RX group). All animals were sacrificed on day33. 02-
generation was assessed by lucigenin-amplified chemiluminescence in seg-
ments of injured and uninjured coronary arteries. Uninjured/NO RX segments
(n = 7) and uninjured/RX segments (n = 7) had similar 02- levels (2728 ±
457 and 3540 ± 543 counts per minute/mg tissue dry weight, respectively, p
= NS). Injured/NO RX segments (n = 5) had significantly elevated 02- pro-
duction (7040 ± 1608 cpm/mg, p < 0.05 vs baseline). PEG-SOD therapy in in-
jured/RX segments (n = 7) dramatically restored 02- levels to normal (3167
± 681 cpm/mg, p = NS vs uninjured, p < 0.05 vs injured/NO AX).
Thus. PEG-SOD therapy effectively reduces 02- levels in the vessel wall
following balloon injury. Prevention of nitric oxide degradation via this mech-
anism may have important implications for modulation of coronary vascular
tone following balloon injury.
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Superoxide Dlsmutase Reduces Superoxlde Anion
Levels in Balloon-Injured Porcine Coronary Arteries
William D. Anderson, Steven v. Manoukian, Jian Zhang, Timothy E. Peterson,
Gustavo D. Cipolla, J. Jeffrey Marshall, Spencer B. King, David G. Harrison, R.
Wayne Alexander, Charles B. Treasure. Emory University, Atlanta, Georgia
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Adhesiveness of Mononuclear Cells is Increased In
Hypercholesterolemic Humans, and Reduced by the
NO Precursor
Gregor Theilmeier, Bing-yin Wang, Christoff Zalpour, Adrian Ma, Barbara Anderson,
Andreas Wolf, Robert C. Candipan, Philip S. Tsao, John P. Cooke. Stanford
University, Stanford. CA
Enhanced interaction of mononuclear cells with the endothelium is the
first observable event in the development of atherosclerosis. Hypercholes-
terolemia reduces vascular nitric oxide activity. This dysfunction may pro-
mote endothelial monocyte interaction, as NO is a potent inhibitor of ad-
hesion. We have previously shown that dietary L-arginine (Arg) supple-
mentation in hypercholesterolemic rabbits restores NO activity and inhibits
monocyte-endothelial cell interaction, in association with a reduction in
atherogenesis. Accordingly we developed a functional binding assay to as-
sess the adhesiveness of human mononuclear cells. so as to determine the
effects of hypercholesterolemia and L-arginine therapy. We found a 50% in-
crease in adhesion of mononuclear cells (MNC) from hypercholesterolemic
(HC) subjects to cultured endothelial cells ex vivo compared to a normo-
cholesterolemic control population (p < 0.0001. n = 20). Increased MNC
adhesion was reversed to normal levels by preincubation of the MNC sus-
pension with 10-5 M sodium nitroprusside (164.4 ± 8.7% vs 97.5 ± 6.9%,
P < 0.0005, n = 7). while L-nitroarginine and Arg did not have an effect in
vitro. In a double-blinded placebo-controlled study, oral Arg (8.4 g/day) was
administered to 7 HC subjects. Over a course of two weeks, this treatment
abolished the increased adhesion (158.5 ± 10.9% vs 103.5 ± 4.9% vs 100 ±
5.2%, HCvs Arg vs Control. p < 0.005), while MNC adhesion remained signif-
icantlyelevated in placebo-treated subjects. Conclusion: The adhesiveness
of human mononuclear cells is increased by hypercholesterolemia. The in-
crease in adhesiveness is reversed in vitro by NO donors, and reversed in
vivo by treatment with the NO precursor L-arginine.
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Platelet Inhibitory Effect of Endothelium-derived
Relaxing Factor in the Human Coronary Circulation
Neil P. Andrews, Nader Dakak, William H. Schenke, Arshed A. Quyyumi. Nab'onal
Institutes ofHealth, Bethesda, MD
Introduction: Endothelium-derived relaxing factor (EDAFI inhibits platelet ac-
tivation by increasing platelet cyclic GMP content. In the human coronary
circulation the vasodilator effect of EDRF released abluminally from the en-
dothelium is well described. but the effects of luminal release of EDRF
on platelets is unknown. Furthermore, whether decreased vasodilator re-
sponses to agents that stimulate EDRF release are also associated with an
abnormal platelet response is unknown.
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Group P1 -adrenergic P2-adrenergic Atrial natriuretic a-myosin
receptor receptor peptide heavy chain
IDC (n = 5) 0.44 ± 0.31 3.29 ± 1.04 23.4 ± 12.4 183 ± 4.61
PPH (n = 3) 0.29 ± 0.08 5.93 ± 1.29 58.2 ± 20.3 10.7 ± 3.44
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1766-31 Fingerprinting Analysis of mRNA from Restenotic
and Primary Atherosclerotic Coronary Plaque
Material Obtained by Atherectomy
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X-Linked Cardiomyopathy: Selective Deficiency of
Dystrophin mRNA and Protein in the Heart
pies are identical. (2) fibronectin levels are increased in R samples, and (3)
the AP-PCR method will be useful to identify novel differentially expressed
gene products. This is the first use of the AP-PCR method to compare gene
expression in restenotic and primary atherosclerotic lesions.
Roger D. Bies. Emma Holder, Masato Maeda Cardiology Division, Temple Hoyne
Buell Laboratories, University of Colorado Health Sciences Center. Denver. CO
Mutations in the membrane associated cytoskeletal protein dystrophin is
typically associated with Duchenne and Beckers Muscular Dystrophy. In-
some cases dystrophin mutations appear causes a selective cardiomyopa-
thy with little skeletal muscle disease. The molecular mechanisms which
cause this phenotype have not been defined. We are particularly interested
in how a mutation in a protein normally expressed in all muscle tissues can
selectively cause disease in the heart. Most cardiomyopathic dystrophin mu-
tations occur at the 5' end of the gene. suggesting that regulatory elements
may playa role in the cardiac specific phenotype. We have analyzed car-
diac and skeletal muscle dystrophin mRNA and protein from a family with
severe cardiomyopathy, and a 5' duplication in exons 2-7 of the dystrophin
gene. Sequence analysis of cDNA across the mutation site, showed no differ-
ence between heart and skeletal muscle transcripts. However, ribonuclease
protection assay demonstrated markedly diminished dystrophin transcript
in the heart. Western blot and immunocytochemistry showed marked re-
duction in cardiac dystrophin protein compared with skeletal muscle. These
results demonstrate that mutations in the 5' dystrophin gene can cause car-
diomyopathy without significant muscle disease by a selective reduction of
dystrophin gene expression in the heart.
Annexins are a unique family of calcium-dependent, phospholipid-binding
proteins found in various tissues. Annexin VI. a major member in the family,
exists in the heart and acts as a potent regulator of the sarcoplasmic reticu-
lum calcium-release channel. cardiac L-type calcium channel and Na+/Ca2+
exchanger. To investigate the role of the regUlation of annexin VI in intra-
cellular calcium homeostasis and mechanical properties of cardiomyocytes.
we used the transgenic mice which overexpresses annexin VI (TG. n = 6)
and control mice (C. n = 6) at three months of age. A 10-fold increase in
annexin VI was revealed by Western blotting in TG mice compared to the
controls. No differences were found between TG and C groups in heart/body
wt., lunglbody wt. or myocyte size.
Cardiomyocytes from TG and C mice were isolated and field paced at 0.25,
0.5 and 1.0 Hz (15,30 and 60 beats per minute). The myocytes of TG mice
demonstrated significant decreases in shortening fraction (% shortening,
TG vs C, 4.59 ± 0.42 vs 8.62 ± 0.85, P < 0.01), rate of shortening (+dl/dt.
j.Lm/sec, TG vs C, 93.54 ± 24.31 vs 148.77 ± 20.23, P < 0.05) and rate of
relengthening (-dl/dt. /<.m/sec, TG vs C, 59.28 ± B.32 vs 119.66 ± 15.94. P <
0.01) at 1.0, but not at 0.25 or 0.5 Hz stimulation. FURA-2 loaded myocytes
from TG mice showed lower baseline levels of calcium at all three stimula-
tion frequencies respectively (340/380 ratio, TG vs C, 0.526 ± 0.075 vs 0.968
± 0.550 at 0.25 Hz, P < 0.001; 0.566 ± 0.044 vs 0.9B2 ± 0.050 at 0.5 Hz, P <
0.001; 0.564 ± 0.043 vs 1.016 ± 0.051 at 1.0 Hz, P < 0.001). The amplitude
of calcium signals decreased in annexin VI TG mice at 0.25 Hz (340/380 ratio.
TG vs C, 0.974 ± 0.14B vs 0.541 ± 0.082, P < 0.05) and at 0.5 Hz stimulation
(0.858 ± 0.141 vs 0.503 ± 0.077, P < 0.05). The duration of calcium signals
was attenuated in TG mice compared to control at 0.25 Hz (sec, 1.033 ±
0.227 vs 1.507 ± 0.150, P < 0.05)
We conclude that overexpression of annexin VI in mouse myocytes causes
depression in the intracellular free calcium concentration. and frequency-
dependent depression in the extent and rate of the shortening and relength-
ening.
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1766-51 Depressed Intracellular Calcium Homeostasis and
Mechanical Properties of Cardlomyocytes In Annexin
VI Transgenic Mouse
Guojie Song, Ann-Marie E. Gunteski-Hamblin, Gerald W. Darn II, Darryl
L. Kirkpatrick. John R. Dedman, Richard A. Walsh. University of Cincinnah' College of
Medicine, Cincinnati, Ohio
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Acute MI patients (n = 180)
Healthy controls In = 430)
ACE genotype
Conclusion: The approximate allele frequency as well as odds ratio of the
DD genotype is in our study in accordance with other findings (0.53-1.34,
Cambien et ai, Nature 1992;359:641). ACE gene polymorphism is related
to acute MI. its importance in relation to other risk factors needs to be as-
sessed.
circulating ACE activity and to hypertrophic cardiomyopathy. heart failure in
general and maybe also to myocardial infarction (MI). This marker is a dele-
tion (D) or insertion (I) of a gene sequence. This generates three different
genotypes 11.10 and DO.
Aim of study: To prospectively study ACE gene polymorphism in consec-
utive acute MI patients and healthy controls both groups without upper age
limits.
Resu/ts: The genotype frequency is presented in the table. The 0 allele had
approximate frequency of 0.52 in the control group and 0.58 in the acute MI
group. The DO/II ratio was higher in the acute MI group (p < 0.05). Odds ratio
for the DD genotype was 1.35 (confidence interval 0.94--1 .97).
Conclusions:
1. Gene expression can be measured in vivo in endomyocardial biopsies
using RT-OPCA.
2. Using 3-6 endomyocardial biopsies we estimate that mRNA abundance
can be measured for as many as 30 genes of interest.
3. Concentrically hypertrophied myocardium may have a different gene
expression pattern than failing myocardium.
David C. Sane, Nicholaos P. Xenopoulos. Gregory A. Braden. The Bowman Gray
School ofMedicine of Wake Forest University, Winston-Salem, NC
In order to compare the expression of gene products in coronary artery
restenotic (R) lesions versus that in primary atherosclerotic (A) lesions, we
performed RNA fingerprinting of 6 Rand 20 A tissue samples obtained by di-
rectional coronary atherectomy. Poly A+ RNA was extracted and cONA was
produced using AMV reverse transcriptase. Priming was performed using
either oligo dT or an arbitrary primer for first strand synthesis. Arbitrarily-
primed PCR (AP-PCR) amplification of the resultant cDNA was performed
using either a single arbitrary 17-mer or a combination of 2 arbitrary 20-mers
as primers. PCR conditions were adjusted to enhance arbitrary priming and
included a high initial Mg++ concentration (4 mMI, high initial primerconcen-
tration (10 /<.M), and low annealing temperature (40°C). Subsequent cycles
(total of 40) were performed under high stringency conditions and included
10 /<.Ci of dCTP. The PCR products were separated on a 4.5% sequencing
gel and subjected to autoradiography, revealing >50 bands of ",100-500 bp
in size. Two products were expressed at higher levels in R than A samples.
These products were reamplified using the original primers, TA cloned and
sequenced, revealing fibronectin and a unique gene product not found in
GenBank. Our results suggest that: (1). most gene products in R and A sam-
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1766-21 In Vivo Measurement of Myocardial Gene Expression
in the Human Heart
Wayne Minobe, Brian D. Lowes. William 1. Abraham. Arthur M. Feldman, Michael
R. Bristow University of Colorado Health Sciences Center. Denver. Colorado; University
of Pittsburgh Heart Institute, Pittsburgh, Pennsylvania
We have previously described a quantitative method for measuring mRNA
abundance in endomyocardial biopsy-sized pieces of human heart. This
method. reverse transcription-quantitative PCR (RT-OPCRI. uses a known
amount of in vitro transcribed internal standard to generate simultaneously
amplified unknown and standard products in the same amplification reac-
tion. We now describe the use of this method to actually measure mRNA
abundance for genes of interest in endomyocardial biopsy specimens re-
moved from subjects with either idiopathic dilated cardiomyopathy (IDC)
and systolic dysfunction (LVEF = 16.B%, RVEF = 27.7%) or primary pul-
monary hypertension (PPH) and right ventricular hypertrophy. (Results are
in molecules mRNA x 105//<.g total RNA ± SEM)
